You have no items in your shopping cart.
You have no items in your shopping cart.
Catalog Number | orb692130 |
---|---|
Category | Small Molecules |
Description | BAL3833 (also known as CCT3833) is an orally available small-molecule panRAF/SRC kinase inhibitor targeting cell proliferation signaling pathways that are associated with tumor growth and resistance development to current therapies. Data from preclinical studies suggest that this class of compounds, targeting the BRAF, CRAF and SRC family kinases, is active in diverse patient-derived melanoma models with intrinsic or acquired resistance to currently marketed BRAF-specific as well as MEK inhibitor therapies.8 Moreover, activity of BAL3833 has also been demonstrated in KRAS-driven cancer models, including non-small cell lung cancer, colorectal cancer and pancreatic cancer.9 BAL3833 has been progressed into a phase 1 study in adult patients with advanced solid tumors including metastatic melanoma. |
CAS Number | [1777832-90-2] |
MW | 531.51 |
SMILES | O=C(NC1=CC(C(C)(C)C)=NN1C2=CC=CC(F)=C2)NC3=CC=C(OC4=C(N=C5)C(NC5=O)=NC=C4)C=C3F |
Formula | C27H23F2N7O3 |
Hazard Information | Non-Toxic |
Note | For research use only |
Expiration Date | 12 months from date of receipt. |
Filter by Rating